The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 612.00
Bid: 612.00
Ask: 614.00
Change: -2.00 (-0.33%)
Spread: 2.00 (0.327%)
Open: 620.00
High: 620.00
Low: 612.00
Prev. Close: 614.00
PRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close trading update and acquisition

6 Dec 2011 07:00

RNS Number : 3920T
Porvair PLC
06 December 2011
 



For immediate release 6 December 2011

 

Porvair plc ("Porvair")

Pre-close trading update and acquisition

 

Porvair, the specialist filtration and environmental technologies group, makes the following announcements regarding trading for the year ended 30 November 2011 and an acquisition by its Seal Analytical ("Seal") subsidiary:

 

Porvair traded well in the final quarter of 2011 and the Board expects to report results ahead of expectations for the year. Revenues for the year, at constant exchange rates, are expected to be 9% higher than the prior year and profit before tax is expected to be substantially ahead. Strong cash flows have reduced net borrowings by more than 40% compared with the prior year to below £5.5m.

 

Revenue at the Metals Filtration division, at constant currency, will be over 15% higher than the prior year. Operating profit has improved significantly compared with the prior year due to revenue growth and higher margins derived from new products that have been introduced in recent years.

 

Revenue at the Microfiltration division, at constant currency, will be around 5% higher than the prior year. Aviation filtration revenue grew strongly in the year and order books for 2012 are encouraging. Seal has traded satisfactorily in the second half with revenues in line with the prior year.

 

Underlying order books across the Group for the first quarter of 2012 are healthy with the recently announced order from POSCO taking the current order book to record levels.

 

On 5 December, Seal acquired a complementary product line from Aim Lab Automation Technologies Pty Ltd. The acquisition will add a line of block digestion instruments and consumables to Seal's range of water quality analysis products and will be sold through Seal's existing distribution and sales channels. Production and customer service will be transferred to Seal's facility in Wisconsin. This small transaction is expected to contribute to Group profitability from acquisition. 

 

Porvair will announce its preliminary results for the year ended 30 November 2011 on Tuesday 31 January 2012.

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Buchanan

0207 466 5000

Charles Ryland / Catherine Breen

 

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration and environmental technology businesses. Its products are used in a range of niche filtration markets, and are derived from its expertise in the design and manufacture of filtration systems using ceramic, metal, plastic and carbon media. Its Seal Analytical business is a market leader in the manufacture of laboratory based water analysis equipment.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVABRAVAURAA
Date   Source Headline
23rd Apr 20241:38 pmRNSDirector/PDMR Shareholding
16th Apr 20242:56 pmRNSAGM Results Announcement
16th Apr 20247:00 amRNSAGM Trading Update & Board Update
3rd Apr 20247:00 amRNSDirector resignation
12th Mar 20247:00 amRNSDirector declaration
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20244:41 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSResults for the year ended 30 November 2023
1st Feb 20247:00 amRNSBlock listing Interim Review
19th Dec 202310:25 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSTrading Update & Acquisition
4th Dec 202312:00 pmRNSHolding(s) in Company
25th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSNine Month Trading Update
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSAcquisition completion
7th Jul 20234:00 pmRNSBlock Listing Application
3rd Jul 20237:00 amRNSInterim Results
26th Jun 20237:00 amRNSBoard Change
21st Jun 20234:22 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSBlock listing Interim Review
4th May 20237:00 amRNSAcquisitions
18th Apr 202312:51 pmRNSAGM resolutions
18th Apr 20237:00 amRNSAGM Trading Update
31st Mar 20234:00 pmRNSTotal Voting Rights
22nd Mar 20233:03 pmRNSGrant of options
1st Mar 20239:30 amRNSTotal Voting Rights
2nd Feb 20235:42 pmRNSGrant of LTSP awards
30th Jan 20237:00 amRNSResults for the year ended 30 November 2022
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSTrading Update, Notice of Results and Board Change
1st Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 202210:00 amRNSTotal Voting Rights
29th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20224:00 pmRNSBlock listing Interim Review
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20229:30 amRNSDirector declaration and resignation
12th Oct 20224:26 pmRNSDirector/PDMR Shareholding
5th Oct 20225:30 pmRNSHolding(s) in Company
5th Oct 20225:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSTrading Update-Ahead of Expectations
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension
13th Sep 20227:00 amRNSNine Month Trading Update
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.